Seroprevalence of SARS-CoV-2 antibodies in a prospective cohort of patients admitted to an acute psychiatric ward in Norway during the initial months of the COVID-19 pandemic

References

• Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. doi: 10.1016/j.jaut.2020.102433.
   PubMed Web of Science ®Google Scholar
• Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–160.
   PubMedGoogle Scholar
• Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles’ heel of current strategies to control covid-19. N Engl J Med. 2020;382(22):2158–2160. doi: 10.1056/NEJMe2009758.
   PubMed Web of Science ®Google Scholar
• Xiang F, Wang X, He X, et al. Antibody detection and dynamic characteristics in patients with coronavirus disease 2019. Clin Infect Dis. 2020;71(8):1930–1934.
   PubMed Web of Science ®Google Scholar
• Ribe AR, Vestergaard M, Katon W, et al. Thirty-day mortality after infection among persons with severe mental illness: a population-based cohort study in Denmark. Am J Psychiatry. 2015;172(8):776–783. doi: 10.1176/appi.ajp.2015.14091100.
   PubMed Web of Science ®Google Scholar
• Chen YH, Lin HC, Lin HC. Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophr Bull. 2011;37(5):1088–1094. doi: 10.1093/schbul/sbq019.
   PubMed Web of Science ®Google Scholar
• Yao H, Chen JH, Xu YF. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21. doi: 10.1016/S2215-0366(20)30090-0.
   PubMed Web of Science ®Google Scholar
• Nemani K, Li C, Olfson M, et al. Association of psychiatric disorders with mortality among patients with COVID-19. JAMA Psychiatry. 2021;78(4):380–386. doi: 10.1001/jamapsychiatry.2020.4442.
   PubMed Web of Science ®Google Scholar
• Barcella CA, Polcwiartek C, Mohr GH, et al. Severe mental illness is associated with increased mortality and severe course of COVID-19. Acta Psychiatr Scand. 2021;144(1):82–91. doi: 10.1111/acps.13309.
   PubMed Web of Science ®Google Scholar
• Fond G, Nemani K, Etchecopar-Etchart D, et al. Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78(11):1208–1217. doi: 10.1001/jamapsychiatry.2021.2274.
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi: 10.1038/s41586-020-2521-4.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLOS One. 2011;6(9):e24597. doi: 10.1371/journal.pone.0024597.
   PubMed Web of Science ®Google Scholar
• Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20(1):124–130. doi: 10.1002/wps.20806.
   PubMed Web of Science ®Google Scholar
• Tzur Bitan D, Krieger I, Kridin K, et al. COVID-19 prevalence and mortality among schizophrenia patients: a large-scale retrospective cohort study. Schizophr Bull. 2021;47(5):1211–1217. doi: 10.1093/schbul/sbab012.
   PubMed Web of Science ®Google Scholar
• Sass MR, Juul TS, Skov R, et al. SARS-CoV-2 seroprevalence among patients with severe mental illness: a cross-sectional study. PLOS One. 2022;17(3):e0264325. doi: 10.1371/journal.pone.0264325.
   PubMed Web of Science ®Google Scholar
• van der Meer D, Pinzón-Espinosa J, Lin BD, et al. Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study. BJPsych Open. 2020;6(5):e87. doi: 10.1192/bjo.2020.75.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793. doi: 10.1001/jama.2020.12839.
   PubMed Web of Science ®Google Scholar
• Bielecki M, Züst R, Siegrist D, et al. Social distancing alters the clinical course of COVID-19 in young adults: a comparative cohort study. Clin Infect Dis. 2021;72(4):598–603. doi: 10.1093/cid/ciaa889.
   PubMed Web of Science ®Google Scholar
• Bi Q, Lessler J, Eckerle I, et al. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021;12(1):3643. doi: 10.1038/s41467-021-23733-5.
   PubMed Web of Science ®Google Scholar
• Lyngse FP, Kirkeby CT, Halasa T, et al. COVID-19 transmission within Danish households: a nationwide study from lockdown to reopening. medRxiv; 2020. doi: 10.1101/2020.09.09.20191239.
   Google Scholar
• Kuwelker K, Zhou F, Blomberg B, et al. Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: a case-ascertained study. Lancet Reg Health Eur. 2021;3:100014. doi: 10.1016/j.lanepe.2020.100014.
   PubMedGoogle Scholar
• Crapanzano KA, Smith S, Hammarlund R. Factors influencing elevated mortality rates of patients with schizophrenia hospitalized with COVID. Community Ment Health J. 2022;58(6):1088–1092. doi: 10.1007/s10597-021-00917-3.
   PubMed Web of Science ®Google Scholar
• Liu Y, Morgenstern C, Kelly J, et al. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC Med. 2021;19(1):40. doi: 10.1186/s12916-020-01872-8.
   PubMed Web of Science ®Google Scholar
• Zhang E, LeQuesne E, Fichtel K, et al. In-patient psychiatry management of COVID-19: rates of asymptomatic infection and on-unit transmission. BJPsych Open. 2020;6(5):e99. doi: 10.1192/bjo.2020.86.
   PubMed Web of Science ®Google Scholar
• Norwegian Resource Center for Community Mental Health (NAPHA). Consequences of covid-19 for mental health municipal services in Norway; Trondheim, Norway, 2020.
   Google Scholar
• The Norwegian Ministry of Education and Research. Coronavirus Special Committee Report; 2023.
   Google Scholar
• Röthlin Eriksen AR, Fogh K, Hasselbalch RB, et al. SARS-CoV-2 antibody prevalence among homeless people, sex workers and shelter workers in Denmark: a nationwide cross-sectional study. medRxiv; 2021. doi: 10.1101/2021.05.07.21256388.
   Google Scholar
• Norwegian Institute for Urban and Regional Research (NIBR). Bostedsløse i Norge 2020 – en kartlegging; Oslo, Norway, 2020.
   Google Scholar
• Leonhardt M, Brodahl M, Cogan N, et al. How did the first COVID-19 lockdown affect persons with concurrent mental health and substance use disorders in Norway? A qualitative study. BMC Psychiatry. 2022;22(1):179. doi: 10.1186/s12888-022-03812-7.
   PubMed Web of Science ®Google Scholar
• Seppälä E, Tønnessen R, Veneti L, et al. COVID-19 cases reported to the Norwegian Institute of Public Health in the first six weeks of the epidemic. Tidsskr Nor Laegeforen. 2020;140(18). doi: 10.4045/tidsskr.20.0525.
   Google Scholar
• Afzal M, Siddiqi N, Ahmad B, et al. Prevalence of overweight and obesity in people with severe mental illness: systematic review and meta-analysis. Front Endocrinol. 2021;12:769309. doi: 10.3389/fendo.2021.769309.
   PubMedGoogle Scholar
• De Hert M, Mazereel V, Detraux J, et al. Prioritizing COVID-19 vaccination for people with severe mental illness. World Psychiatry. 2021;20(1):54–55. doi: 10.1002/wps.20826.
   PubMed Web of Science ®Google Scholar